Advanced Search

Study Preview



Study Title and Description

The safety and effectiveness of ledipasvir-sofosbuvir in adolescents 12-17 years old with hepatitis C virus genotype 1 infection.



Key Questions Addressed
6 Key Question 6. What is the effectiveness of currently recommended antiviral treatments in improving health outcomes in patients with HCV infection?
  • Comments Comments (
    0
    ) |
7 Key Question 7. What is the effectiveness of currently recommended antiviral treatments in achieving a SVR in patients with HCV infection?
  • Comments Comments (
    0
    ) |
8 Key Question 8. What are the harms of currently recommended antiviral treatments?
  • Comments Comments (
    0
    ) |

Primary Publication Information
  • Comments Comments (
    0
    ) |
TitleData
Title The safety and effectiveness of ledipasvir-sofosbuvir in adolescents 12-17 years old with hepatitis C virus genotype 1 infection.
Author Balistreri WF., Murray KF., Rosenthal P., Bansal S., Lin CH., Kersey K., Massetto B., Zhu Y., Kanwar B., German P., Svarovskaia E., Brainard DM., Wen J., Gonzalez-Peralta RP., Jonas MM., Schwarz K.
Country Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
Year 2017
Numbers Pubmed ID: 27997679

Secondary Publication Information
There are currently no secondary publications defined for this study.


Extraction Form: Key Questions 1-9


Results & Comparisons

No Results found.